Aberrant expression of N-acetylglucosaminyltransferase-IVa and IVb (GnT-IVa and b) in pancreatic cancer.
about
N-glycan alterations are associated with drug resistance in human hepatocellular carcinomaEnzymes for N-Glycan Branching and Their Genetic and Nongenetic Regulation in CancerPhysiological and glycomic characterization of N-acetylglucosaminyltransferase-IVa and -IVb double deficient miceEvolutional and clinical implications of the epigenetic regulation of protein glycosylation.Compartmentalization of the Edinburgh Human Metabolic Network.The transcription of MGAT4A glycosyl transferase is increased in white cells of peripheral blood of type 2 diabetes patients.Control of Glycosylation-Related Genes by DNA Methylation: the Intriguing Case of the B3GALT5 Gene and Its Distinct PromotersReversibility of membrane N-glycome of HeLa cells upon treatment with epigenetic inhibitors.Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk.Specific N-glycans of Hepatocellular Carcinoma Cell Surface and the Abnormal Increase of Core-α-1, 6-fucosylated Triantennary Glycan via N-acetylglucosaminyltransferases-IVa Regulation.Current evidence for histone deacetylase inhibitors in pancreatic cancer.Multiplexed surrogate analysis of glycotransferase activity in whole biospecimensGenomics and epigenomics of the human glycome.Applications of microarray technology to pancreatic cancer research and drug development.Tumor suppressor p16INK4a--modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells.N-acetylglucosaminyltransferase IVa regulates metastatic potential of mouse hepatocarcinoma cells through glycosylation of CD147.Epigenetic regulation of protein glycosylation.Addition of GlcNAc to position 4 by N-acetylglucosaminyltransferase (GnT)-IVFocused microarray analysis of glyco-gene expression in human glioblastomas.Tumor suppressor p16 INK4a: Downregulation of galectin-3, an endogenous competitor of the pro-anoikis effector galectin-1, in a pancreatic carcinoma model.
P2860
Q21245732-E710C6DE-EEAC-40DC-A2E9-950E93F3F8B4Q26748089-390334B8-478E-4FFD-A3B3-09708B684FDEQ28508858-97B90DDD-444E-46BC-9919-5B79AF77449DQ30418119-28F1EA95-FB6F-4616-8146-77339EFA60B8Q30986319-35BD1F81-7875-4C9E-89DB-A6003A68D36BQ33303486-452E574F-6F51-4385-A772-44ED29C967F0Q34317986-8833F450-4DAA-4F5C-8869-3A24659F2144Q34555935-3EDBC625-3A2A-433C-889B-840809B59CA6Q35921826-9447B9A4-E27F-4CBB-900C-E223C0F25F8CQ36249639-93AB87EF-B2D8-4CB8-890B-79404BA7B1B0Q36616790-449F9E5F-B847-4C6D-A4F2-1DFDAFE9B46BQ36833668-56B460F5-6C69-4863-BB1C-48E5CD958DE8Q38014677-A07E121D-B626-4CCC-BED5-AE9B37D24439Q38089806-40C2A3CC-B165-4098-B7AA-B8E3E6004093Q38301301-ACD5D779-BAA4-462F-AAA3-C73EB8022994Q39324563-35459AE6-421A-4692-A521-96EB5AAF31DBQ47356836-3E631692-A6D9-4748-BDF1-9006575A3423Q50296342-2628C5B4-8D4E-4753-98F3-DE9F2F95EFCEQ50852489-98363E95-24A1-42B1-B6C3-F4B4DC1825AAQ54657364-0099360A-01CC-4A9C-8543-1FA6817EE81F
P2860
Aberrant expression of N-acetylglucosaminyltransferase-IVa and IVb (GnT-IVa and b) in pancreatic cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Aberrant expression of N-acety ...... a and b) in pancreatic cancer.
@en
type
label
Aberrant expression of N-acety ...... a and b) in pancreatic cancer.
@en
prefLabel
Aberrant expression of N-acety ...... a and b) in pancreatic cancer.
@en
P2093
P1476
Aberrant expression of N-acety ...... a and b) in pancreatic cancer.
@en
P2093
Eiji Miyoshi
Harumi Yamamoto
Jianguo Gu
Masahiro Tanemura
Naoyuki Taniguchi
Toshinori Ito
Toshiro Nishida
Tsutomu Nakagawa
Yasunori Kozutsumi
Yoshihito Ide
P304
P356
10.1016/J.BBRC.2005.12.208
P577
2006-01-11T00:00:00Z